Latest News

Tuesday, November 25, 2014 | Earnings & Financials

Eleven Biotherapeutics Announces Additional Financing of $20 Million

Eleven Biotherapeutics announced that it has entered into a securities purchase agreement for the sale of $20 million of Eleven Biotherapeutics common stock and warrants in a private placement financi…

Read the full story

Tuesday, November 25, 2014 | Clinical Trials

R-Tech Ueno Receives Orphan Drug Designation in Japan for Unoprostone Isopropyl (UF-021) for the Treatment of Retinitis Pigmentosa

R-Tech Ueno announced that it has received orphan drug designation from the Ministry of Health, Labour and Welfare (MHLW) for Unoprostone Isopropyl (Unoprostone, development code: UF-021) for the trea…

Read the full story

Tuesday, November 25, 2014 | Medical Studies

Blinking Exercises Help Ease Evaporative Dry Eye

In patients with evaporative dry eye, blinking exercises can help decrease partial blinking and improve meibomian gland function and symptoms, according to a new study. Detecting and quantifying parti…

Read the full story

Tuesday, November 25, 2014 | Medical Studies

Office Test Overestimates Eye's Ability to Change Focus in Preschoolers

In preschool-aged children, a simple test performed in the ophthalmologist's or optometrist's office greatly overestimates the eye's ability to "flex and focus" in order to see s…

Read the full story

Monday, November 24, 2014 | Miscellaneous

HelpMeSee Joins the National #GivingTuesday Movement To Encourage Spending With A Purpose

HelpMeSee -- a global campaign to cure cataract blindness - has joined #GivingTuesday, with a global ambassador video search contest, a first-of-its-kind effort that will harness the collective powe…

Read the full story

Monday, November 24, 2014 |

Ora-CAC Model Provided Platform for Recent Positive Phase 2 Data for Ocular Therapeutix's OTX-DP in Allergic Conjunctivitis

Ora Inc. announced that its Conjunctival Allergen Challenge (Ora-CAC) model provided a platform for the successful phase 2 clinical results of sustained-release Dexamethasone (OTX- DP), a drug-eluting…

Read the full story

Monday, November 24, 2014 | Medical Studies

CDC: Improper Contact Lens Care Can Lead to Blindness

Contact lenses - worn by around 38 million Americans - are a popular alternative to wearing glasses. But improper care of contact lenses can cause eye infections like keratitis, which can lead to blin…

Read the full story

Monday, November 24, 2014 | Medical Studies

Artificial Retina Could Someday Help Restore Vision

The loss of eyesight, often caused by retinal degeneration, is a life-altering health issue for many people, especially as they age. But a new development toward a prosthetic retina could help counter…

Read the full story

Friday, November 21, 2014 | Earnings & Financials, Allergan, Valeant Ophthalmics

Valeant Slashes Stake in Allergan After Losing Bid

Valeant Pharmaceuticals International said it cut its stake in Allergan to 0.1 percent from 9.7 percent, three days after Actavis Plc trumped its offer for the Botox maker. Pershing Square Capital Man…

Read the full story

Friday, November 21, 2014 | Medical Studies

Telemedicine Screening for Diabetic Retinopathy Finds Condition in 1 of 5 Patients

A telemedicine program to screen for diabetic retinopathy (a leading cause of blindness) at urban clinics and a pharmacy predominantly serving racial/ethnic minority and uninsured patients with diabet…

Read the full story

Friday, November 21, 2014 | Clinical Trials

Further Scientific and Clinical Research Validating the Clinical Efficacy of 2RT for Early AMD Published

Ellex Medical Lasers Limited announced that additional positive scientific and clinical research on the therapeutic and safety profile of the company’s proprietary Retinal Rejuvenation (2R…

Read the full story

Friday, November 21, 2014 | Medical Studies

World’s Drug Bill Will Reach $1.3 Trillion in 2018: Study

Worldwide spending on medicines will reach almost $1.3 trillion by 2018, as new treatments for hepatitis C and cancer come to market and as people around the globe use rising incomes to buy pharmaceut…

Read the full story

Thursday, November 20, 2014 | Miscellaneous

$152,000 Raised to Help Blind and Visually Impaired at 2014 Eye Ball Gala

Passionate advocates for the blind and visually impaired as well as cornea transplant surgeons gathered at the 2014 Eye Ball Gala, raising $152,000 to help give the gift of sight. Each year, the Lions…

Read the full story

Thursday, November 20, 2014 | Clinical Trials

Drug Trial Results Can’t Be Hidden Under Proposed Rules

Pharmaceutical companies, medical device makers and academic medical centers would no longer be able to withhold the results of clinical trials under rules proposed by the U.S. Department of Health an…

Read the full story

Thursday, November 20, 2014 | Medical Studies

Identifying Eye Diseases by Studying Eye Movements of People Watching TV

One of the leading causes of blindness worldwide could be detected by how our eyes respond to watching TV according to a new study from researchers at City University London. The researchers, who were…

Read the full story
Load More

Advertisement

 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $27.24  0.00% 
 Akorn, Inc. $38.04  0.00% 
 Alimera Sciences, Inc. $5.79  0.00% 
 Allergan, Inc. $212.10  0.00% 
 Avalanche $38.69  0.00% 
 Bayer $146.94  0.00% 
 Can-Fite Biopharma $3.94  0.00% 
 Carl Zeiss Meditec $22.21  -1.09% 
 Cooper Companies, Inc. $166.65  0.00% 
 Escalon Medical Corp. $1.41  0.00% 
 Essilor International $110.50  0.00% 
 Imprimis Pharmaceuticals, Inc. $8.11  0.00% 
 InSite Vision, Inc. $0.25  0.00% 
 IRIDEX Corporation $8.44  0.00% 
 Johnson & Johnson $106.70  0.00% 
 LCA-Vision Inc. $5.37  0.00% 
 Luxottica Group, S.p.A. $52.97  0.00% 
 Merck & Company, Inc. $59.34  0.00% 
 NicOx $2.06  -0.19% 
 NovaBay Pharmaceuticals, Inc. $0.70  0.00% 
 Novartis AG Common Stock $95.04  0.00% 
 Ocular Therapeutix $18.19  0.00% 
 Ophthotech Corporation $42.33  0.00% 
 Quantel $3.14  -1.57% 
 Regeneron $413.00  0.00% 
 Roche $37.21  0.00% 
 STAAR Surgical Company $9.42  0.00% 
 TearLab Corporation $2.90  0.00% 
 Thrombogenics $8.60  0.00% 
 Topcon Corporation $23.40  0.00% 
 Valeant Pharmaceuticals $144.76  0.00% 
 Xoma $5.52  0.00%